HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic value of PLCE1 expression in upper gastrointestinal cancer: a systematic review and meta-analysis.

AbstractBACKGROUND:
A number of studies have identified a shared susceptibility locus in phospholipase C epsilon 1 (PLCE1) for esophageal squamous cell carcinoma (ESCC) and gastric cardia adenocarcinomas (GCA). However, the results of PLCE1 expression in esophageal and gastric cancer remain inconsistent and controversial. Moreover, the effects on clinicopathological features remain undetermined. This study aimed to provide a precise quantification of the association between PLCE1 expression and the risk of ESCC and GCA through meta-analysis.
MATERIALS AND METHODS:
Eligible studies were identified from PubMed, Wanfang Data, ISI Web of Science, and the Chinese National Knowledge Infrastructure databases. Using RevMan5.2 software, pooled odds ratios (ORs) with 95% confidence intervals (CIs) were employed to assess the association of PLCE1 expression with clinicopathological features relative to ESCC or GCA.
RESULTS:
Seven articles were identified, including 761 esophageal and gastric cancer cases and 457 controls. Overall, we determined that PLCE1 expression was associated with tumor progression in both esophageal cancers (pooled OR=5.93; 95%CI=3.86 to 9.11) and gastric cancers (pooled OR=9.73; 95%CI=6.46 to 14.7). Moreover, invasion depth (pooled OR=3.62; 95%CI=2.30 to 5.70) and lymph node metastasis (pooled OR=4.21; 95%CI=2.69 to 6.59) were linked with PLCE1 expression in gastric cancer. However, no significant associations were determined between PLCE1 overexpression and the histologic grade, invasion depth, and lymph node metastasis in esophageal cancer.
CONCLUSIONS:
Our meta- analysis results indicated that upregulated PLCE1 is significantly associated with an increased risk of tumor progression in ESCC and GCA. Therefore, PLCE1 expression can be appropriately regarded as a promising biomarker for ESCC and GCA patients.
AuthorsXiao-Bin Cui, Hao Peng, Su Li, Ting-Ting Li, Chun-Xia Liu, Shu-Mao Zhang, Ting-Ting Jin, Jian-Ming Hu, Jin-Fang Jiang, Wei-Hua Liang, Na Li, Li Li, Yun-Zhao Chen, Feng Li
JournalAsian Pacific journal of cancer prevention : APJCP (Asian Pac J Cancer Prev) Vol. 15 Issue 22 Pg. 9661-6 ( 2014) ISSN: 2476-762X [Electronic] Thailand
PMID25520085 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Review, Systematic Review)
Chemical References
  • Biomarkers, Tumor
  • Phosphoinositide Phospholipase C
  • phospholipase C epsilon
Topics
  • Adenocarcinoma (genetics)
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (biosynthesis, genetics)
  • Carcinoma, Squamous Cell (genetics)
  • Cardia (pathology)
  • Esophageal Neoplasms (genetics)
  • Esophageal Squamous Cell Carcinoma
  • Genetic Predisposition to Disease
  • Humans
  • Lymphatic Metastasis (pathology)
  • Middle Aged
  • Phosphoinositide Phospholipase C (biosynthesis, genetics)
  • Stomach Neoplasms (genetics)
  • Upper Gastrointestinal Tract (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: